The lung cancer community has a unique and urgent opportunity to influence the future of lung cancer research funding in Congress. The Lung Cancer Research Program (LCRP), part of the Congressionally Directed Medical Research Program (CDMRP) within the Department of Defense, is an important source of federal funding for lung cancer research.
It can be difficult to decide what information to disclose at your workplace when navigating a cancer diagnosis.
April is Stress Awareness Month, and for those living with lung cancer, feelings of stress or anxiety can become unwelcome symptoms of the changes and challenges living with lung cancer creates. However, tools like mindset and mindfulness have led to individuals gaining a sense of control over their emotions, including stress.
The American Association for Cancer Research (AACR) 2022 meeting was held in New Orleans from April 9 to 13. Doctors and researchers worldwide joined together virtually and in person to make this year’s meeting one of the largest gatherings since the start of the pandemic. They shared the many exciting developments in cancer research and treatment that emerged over the last year.
On May 28, 2021, the United States Food & Drug Administration (FDA) approved sotorasib as the first targeted therapy for patients with KRAS G12C-positive non-small cell lung cancer (NSCLC).
At LUNGevity, we say that our people are our most valuable asset, and our dedicated volunteers exemplify this. Hundreds of volunteers from across the country support LUNGevity and the community we serve. Volunteers use their unique talents and perspectives to provide peer support, raise awareness for lung cancer, plan events and fundraisers, and advocate.
